NO960607L - Primær og sekundær neurobeskyttende effekt av flupirtin i neurodegenerative sykdommer - Google Patents

Primær og sekundær neurobeskyttende effekt av flupirtin i neurodegenerative sykdommer

Info

Publication number: NO960607L
Authority: NO; Norway
Prior art keywords: pct; flupirtine; primary; neurodegenerative diseases; neuroprotective effects
Prior art date: 1993-08-17

Application number

NO960607A

Other languages

English (en)

Other versions

NO309842B1 (no

NO960607D0 (no

Inventor

Michael Schwarz

Gabriela Pergande

Jurgen Engel

Bernd Nickel

Heinz Ulrich

Stefan Szelenyi

Original Assignee

Asta Medica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-08-17

Filing date

1996-02-15

Publication date

1996-02-15

1996-02-15 Application filed by Asta Medica Ag filed Critical Asta Medica Ag

1996-02-15 Publication of NO960607L publication Critical patent/NO960607L/no

1996-02-15 Publication of NO960607D0 publication Critical patent/NO960607D0/no

2001-04-09 Publication of NO309842B1 publication Critical patent/NO309842B1/no

Links

JUUFBMODXQKSTD-UHFFFAOYSA-N N-[2-amino-6-[(4-fluorophenyl)methylamino]-3-pyridinyl]carbamic acid ethyl ester Chemical compound N1=C(N)C(NC(=O)OCC)=CC=C1NCC1=CC=C(F)C=C1 JUUFBMODXQKSTD-UHFFFAOYSA-N 0.000 title abstract 2
229960003667 flupirtine Drugs 0.000 title abstract 2
208000015122 neurodegenerative disease Diseases 0.000 title abstract 2
230000004770 neurodegeneration Effects 0.000 title 1
230000000324 neuroprotective effect Effects 0.000 title 1
201000006474 Brain Ischemia Diseases 0.000 abstract 1
206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
231100001018 bone marrow damage Toxicity 0.000 abstract 1
210000004556 brain Anatomy 0.000 abstract 1
231100000874 brain damage Toxicity 0.000 abstract 1
206010008118 cerebral infarction Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000000472 traumatic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Epidemiology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Confectionery (AREA)

NO960607A 1993-08-17 1996-02-15 Anvendelse av den aktive substansen flupirtin for fremstilling av et medikament for behandling av sykdommer NO309842B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4327516A DE4327516A1 (de)	1993-08-17	1993-08-17	Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin
PCT/EP1994/002649 WO1995005175A1 (en)	1993-08-17	1994-08-10	The primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases

Publications (3)

Publication Number	Publication Date
NO960607L true NO960607L (no)	1996-02-15
NO960607D0 NO960607D0 (no)	1996-02-15
NO309842B1 NO309842B1 (no)	2001-04-09

Family

ID=6495312

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO960607A NO309842B1 (no)	1993-08-17	1996-02-15	Anvendelse av den aktive substansen flupirtin for fremstilling av et medikament for behandling av sykdommer

Country Status (27)

Country	Link
US (1)	US5721258A (no)
EP (1)	EP0716602B1 (no)
JP (1)	JPH09501664A (no)
KR (1)	KR100341952B1 (no)
CN (1)	CN1086291C (no)
AT (1)	ATE210442T1 (no)
AU (1)	AU694447B2 (no)
BG (1)	BG62430B1 (no)
BR (1)	BR9407293A (no)
CA (1)	CA2169718C (no)
CZ (1)	CZ289040B6 (no)
DE (2)	DE4327516A1 (no)
DK (1)	DK0716602T3 (no)
EE (1)	EE03204B1 (no)
ES (1)	ES2168309T3 (no)
HR (1)	HRP940464A2 (no)
HU (1)	HU227765B1 (no)
IL (1)	IL110681A (no)
NO (1)	NO309842B1 (no)
NZ (1)	NZ273292A (no)
PT (1)	PT716602E (no)
RU (1)	RU2166318C2 (no)
SK (1)	SK283330B6 (no)
UA (1)	UA43351C2 (no)
WO (1)	WO1995005175A1 (no)
YU (1)	YU49215B (no)
ZA (1)	ZA946176B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19539861A1 (de) *	1995-10-26	1997-04-30	Asta Medica Ag	Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
DE19541405A1 (de) *	1995-11-07	1997-05-15	Asta Medica Ag	Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
DE19625582A1 (de) *	1996-06-27	1998-01-02	Asta Medica Ag	Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen die mit einer unphysiologisch hohen Zellsterberate einhergehen
EP1034783B1 (en) *	1997-10-27	2004-12-15	Sumitomo Pharmaceuticals Company, Limited	Amide derivatives for the treatment of retinal neurodegenerative disorders
AU1359801A (en) *	1999-11-05	2001-06-06	Vela Pharmaceuticals Inc.	Methods and compositions for treating reward deficiency syndrome
US6821995B1 (en)	1999-12-01	2004-11-23	Duke University	Method of treating batten disease
WO2001039760A2 (en) *	1999-12-01	2001-06-07	Duke University	Method of treating batten disease
DE10327674A1 (de) *	2003-06-20	2005-01-05	Awd.Pharma Gmbh & Co. Kg	Injizierbare Darreichungsform von Flupirtin
DE10328260A1 (de) *	2003-06-23	2005-01-27	Schmidt, K.-G., Dr. med.	Flupirtine-Präparat
EP1701725B1 (en) *	2003-12-16	2013-07-31	Relevare Aust. Pty Ltd	Compositions comprising flupirtine and an opioid for use in the treatment of neuropathic pain
US20080287399A1 (en) *	2004-12-14	2008-11-20	Astrazeneca Ab	Substituted Aminopyridines and Uses Thereof
EP1688141A1 (en)	2005-01-31	2006-08-09	elbion AG	The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
US20060258708A1 (en) *	2005-05-16	2006-11-16	Andrulis Peter J Jr	Method for treating Parkinson's disease and other neurological diseases
US20080279930A1 (en) *	2007-05-07	2008-11-13	Bernd Terhaag	Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
DE102011006425A1 (de)	2010-03-31	2011-10-06	Awd.Pharma Gmbh & Co. Kg	Pharmazeutische Zubereitung und deren Verwendung
DE102010030053A1 (de)	2010-06-14	2011-12-15	Awd.Pharma Gmbh & Co.Kg	Injizierbare Darreichungsform von Flupirtin
WO2015017565A1 (en) *	2013-07-31	2015-02-05	Teva Pharmaceutical Industries Ltd.	Treatment of multiple sclerosis with combination of laquinimod and flupirtine
WO2019014547A1 (en) *	2017-07-14	2019-01-17	Texas Tech University System	FUNCTIONALIZED PYRIDINE CARBAMATES HAVING ENHANCED NEUROPROTECTOR ACTIVITY
DE102017007385A1 (de)	2017-08-02	2019-02-07	Christoph Hoock	Maleatfreie feste Arzneimittelformen
CN120346203B (zh) *	2025-06-23	2026-01-09	西安交通大学	GluK1受体激动剂在制备治疗慢性疼痛的药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4481205A (en) *	1980-09-13	1984-11-06	Degussa Aktiengesellschaft	2-Amino-3-carbethoxyamino-6-(p-fluoro-benzylamino)-pyridine-maleate
DE3337593A1 (de) *	1982-10-27	1984-05-03	Degussa Ag, 6000 Frankfurt	2-amino-3-acylamino-6-benzylamino-pyridin-derivate mit antiepileptischer wirkung
ATE25078T1 (de) *	1982-10-27	1987-02-15	Degussa	2-amino-3-acylamino-6-benzylamino-pyridinderivate mit anti-epileptischer wirkung.
NO860825L (no) *	1985-03-23	1986-09-24	Degussa	Fremgangsmaate til fremstilling av 2-amino-3-nitro-6-(4-fluor-benzylamino)-pyridin samt 2-amino-3-karbetoksyamino-6-(4-fluor-benzylamino)-pyridin.
EP0517852B1 (en) *	1990-03-02	2002-07-10	STATE OF OREGON, acting by and through THE OREGON STATE BOARD OF HIGHER EDUCATION, acting for and on behalf of	Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
IN172468B (no) *	1990-07-14	1993-08-14	Asta Medica Ag
IL111240A (en) *	1993-10-18	2001-10-31	Teva Pharma	Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them

1993
- 1993-08-17 DE DE4327516A patent/DE4327516A1/de not_active Ceased
1994
- 1994-08-10 HU HU9600355A patent/HU227765B1/hu unknown
- 1994-08-10 PT PT94926828T patent/PT716602E/pt unknown
- 1994-08-10 RU RU96105707/14A patent/RU2166318C2/ru active
- 1994-08-10 US US08/602,742 patent/US5721258A/en not_active Expired - Lifetime
- 1994-08-10 DE DE69429435T patent/DE69429435T2/de not_active Expired - Lifetime
- 1994-08-10 CA CA002169718A patent/CA2169718C/en not_active Expired - Lifetime
- 1994-08-10 ES ES94926828T patent/ES2168309T3/es not_active Expired - Lifetime
- 1994-08-10 SK SK214-96A patent/SK283330B6/sk not_active IP Right Cessation
- 1994-08-10 WO PCT/EP1994/002649 patent/WO1995005175A1/en not_active Ceased
- 1994-08-10 DK DK94926828T patent/DK0716602T3/da active
- 1994-08-10 KR KR1019960700753A patent/KR100341952B1/ko not_active Expired - Lifetime
- 1994-08-10 CZ CZ1996465A patent/CZ289040B6/cs not_active IP Right Cessation
- 1994-08-10 CN CN94193106A patent/CN1086291C/zh not_active Expired - Lifetime
- 1994-08-10 NZ NZ273292A patent/NZ273292A/en not_active IP Right Cessation
- 1994-08-10 AT AT94926828T patent/ATE210442T1/de active
- 1994-08-10 EP EP94926828A patent/EP0716602B1/en not_active Expired - Lifetime
- 1994-08-10 BR BR9407293A patent/BR9407293A/pt not_active Application Discontinuation
- 1994-08-10 JP JP7506731A patent/JPH09501664A/ja active Pending
- 1994-08-10 AU AU76528/94A patent/AU694447B2/en not_active Expired
- 1994-08-15 YU YU51294A patent/YU49215B/sh unknown
- 1994-08-16 IL IL11068194A patent/IL110681A/xx not_active IP Right Cessation
- 1994-08-16 ZA ZA946176A patent/ZA946176B/xx unknown
- 1994-08-16 HR HRP4327516.8A patent/HRP940464A2/hr not_active Application Discontinuation
- 1994-10-08 UA UA96030972A patent/UA43351C2/uk unknown
- 1994-10-25 EE EE9400160A patent/EE03204B1/xx unknown
1996
- 1996-02-14 BG BG100356A patent/BG62430B1/bg unknown
- 1996-02-15 NO NO960607A patent/NO309842B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
HU227765B1 (en)	2012-02-28
UA43351C2 (uk)	2001-12-17
BR9407293A (pt)	1996-10-01
YU51294A (sh)	1998-05-15
NO309842B1 (no)	2001-04-09
HRP940464A2 (en)	1997-06-30
EP0716602A1 (en)	1996-06-19
IL110681A0 (en)	1994-11-11
AU7652894A (en)	1995-03-14
YU49215B (sh)	2004-11-25
CA2169718A1 (en)	1995-02-23
US5721258A (en)	1998-02-24
BG100356A (bg)	1996-07-31
KR960703591A (ko)	1996-08-31
IL110681A (en)	1999-08-17
NZ273292A (en)	1999-09-29
SK21496A3 (en)	1997-01-08
EP0716602B1 (en)	2001-12-12
NO960607D0 (no)	1996-02-15
SK283330B6 (sk)	2003-06-03
RU2166318C2 (ru)	2001-05-10
ATE210442T1 (de)	2001-12-15
DE4327516A1 (de)	1995-02-23
PT716602E (pt)	2002-05-31
EE03204B1 (et)	1999-08-16
ES2168309T3 (es)	2002-06-16
DE69429435D1 (de)	2002-01-24
CZ46596A3 (en)	1996-05-15
WO1995005175A1 (en)	1995-02-23
KR100341952B1 (ko)	2003-04-11
DE69429435T2 (de)	2002-06-13
CN1129399A (zh)	1996-08-21
AU694447B2 (en)	1998-07-23
CZ289040B6 (cs)	2001-10-17
DK0716602T3 (da)	2002-03-25
BG62430B1 (bg)	1999-11-30
CA2169718C (en)	2002-11-12
ZA946176B (en)	1995-03-20
HUT75650A (en)	1997-05-28
JPH09501664A (ja)	1997-02-18
HU9600355D0 (en)	1996-04-29
CN1086291C (zh)	2002-06-19

Legal Events

Date	Code	Title	Description
2014-08-18	MK1K	Patent expired

Publication	Publication Date	Title
NO960607D0 (no)	1996-02-15	Primær og sekundær neurobeskyttende effekt av flupirtin i neurodegenerative sykdommer
IL111077A0 (en)	1994-11-28	Pharmacologically active pyridine derivatives and processes for the preparation thereof
HUT71814A (en)	1996-02-28	Process for producing pharmaceutical compositions for the treatment of neurological lesions related to traumatic injuries
PT703786E (pt)	2002-07-31	Utilizacao de nonapeptideos e decapeptideos para a preparacao de um medicamento para o tratamento da sida
ZA965235B (en)	1997-01-09	Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders
AU4180593A (en)	1994-01-13	The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
IL113941A (en)	2000-02-17	Perfluoroalkyl ketone inhibitors of elastase processes for making the same and pharmaceutical compositions containing them
NZ271363A (en)	1999-06-29	Use of antiglucocorticoid steroids to treat anxiety disorders
GR3035762T3 (en)	2001-07-31	Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
MX9800049A (es)	1998-11-30	Antraquinonas mono- y disulfo-substituidas y su uso para el tratamiento de trastornos de la matriz del hueso.
NZ268914A (en)	1999-06-29	Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease
HU9802142D0 (en)	1998-11-30	Use of na+/h+ -ion-exchange inhibitors for producing pharmaceutical compositions for treating and profilacting diseases of the central nerve system
ZA925983B (en)	1993-08-10	Pharmaceutical compositions for the treatment of skin disorders
UA10259A (uk)	1996-12-25	Протинабряковий лікарський препарат "нейрополіосм"